Björklund A - Search Results

1

Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation.

Tobiasson M, Pandzic T, Illman J, Nilsson L, Weström S, Ejerblad E, Olesen G, Björklund A, Olsnes Kittang A, Werlenius O, Lorentz F, Rasmussen B, Cammenga J, Weber D, Lindholm C, Wiggh J, Dimitriou M, Moen AE, Yip Lundström L, von Bahr L, Baltzer-Sollander K, Jädersten M, Kytölä S, Walldin G, Ljungman P, Groenbaek K, Mielke S, Jacobsen SEW, Ebeling F, Cavelier L, Smidstrup Friis L, Dybedal I, Hellström-Lindberg E. Tobiasson M, et al. Among authors: bjorklund a. J Clin Oncol. 2024 Apr 20;42(12):1378-1390. doi: 10.1200/JCO.23.01159. Epub 2024 Jan 17. J Clin Oncol. 2024. PMID: 38232336

2

Lineage-specific early complete donor chimerism and risk of relapse after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.

Lindahl H, Vonlanthen S, Valentini D, Björklund AT, Sundin M, Mielke S, Hauzenberger D. Lindahl H, et al. Bone Marrow Transplant. 2022 May;57(5):753-759. doi: 10.1038/s41409-022-01615-8. Epub 2022 Feb 24. Bone Marrow Transplant. 2022. PMID: 35210563 Free PMC article.

3

Early relapse prediction after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia (ALL) using lineage-specific chimerism analysis.

Lindahl H, Valentini D, Vonlanthen S, Sundin M, Björklund AT, Mielke S, Hauzenberger D. Lindahl H, et al. EJHaem. 2022 Sep 19;3(4):1277-1286. doi: 10.1002/jha2.568. eCollection 2022 Nov. EJHaem. 2022. PMID: 36467849 Free PMC article.

4

Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation.

von Bahr L, Blennow O, Alm J, Björklund A, Malmberg KJ, Mougiakakos D, Le Blanc A, Oefner PJ, Labopin M, Ljungman P, Le Blanc K. von Bahr L, et al. Among authors: bjorklund a. Bone Marrow Transplant. 2015 Sep;50(9):1217-23. doi: 10.1038/bmt.2015.123. Epub 2015 Jun 1. Bone Marrow Transplant. 2015. PMID: 26030049

5

Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML.

Björklund AT, Carlsten M, Sohlberg E, Liu LL, Clancy T, Karimi M, Cooley S, Miller JS, Klimkowska M, Schaffer M, Watz E, Wikström K, Blomberg P, Wahlin BE, Palma M, Hansson L, Ljungman P, Hellström-Lindberg E, Ljunggren HG, Malmberg KJ. Björklund AT, et al. Clin Cancer Res. 2018 Apr 15;24(8):1834-1844. doi: 10.1158/1078-0432.CCR-17-3196. Epub 2018 Feb 14. Clin Cancer Res. 2018. PMID: 29444931 Clinical Trial.

6

Naive Donor NK Cell Repertoires Associated with Less Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

Björklund AT, Clancy T, Goodridge JP, Béziat V, Schaffer M, Hovig E, Ljunggren HG, Ljungman PT, Malmberg KJ. Björklund AT, et al. J Immunol. 2016 Feb 1;196(3):1400-11. doi: 10.4049/jimmunol.1501434. Epub 2016 Jan 8. J Immunol. 2016. PMID: 26746188

7

Decreased IL-7 signaling in T cells from patients with PTLD after allogeneic HSCT.

Omar H, Ahmed R, Rane L, Björklund A, Gustafsson-Jernberg A, Ljungman P, Maeurer MJ. Omar H, et al. Among authors: bjorklund a. J Immunother. 2011 May;34(4):390-6. doi: 10.1097/CJI.0b013e318215e31b. J Immunother. 2011. PMID: 21499131

8

Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation.

Remberger M, Törlen J, Serafi IE, Garming-Legert K, Björklund A, Ljungman P, Sundin M, Hassan M, Mattsson J. Remberger M, et al. Among authors: bjorklund a. Int J Hematol. 2017 Oct;106(4):471-475. doi: 10.1007/s12185-017-2320-3. Epub 2017 Aug 28. Int J Hematol. 2017. PMID: 28849374

9

Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation.

Bjorklund A, Aschan J, Labopin M, Remberger M, Ringden O, Winiarski J, Ljungman P. Bjorklund A, et al. Bone Marrow Transplant. 2007 Dec;40(11):1055-62. doi: 10.1038/sj.bmt.1705856. Epub 2007 Sep 24. Bone Marrow Transplant. 2007. PMID: 17891187

10

NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation.

Björklund AT, Schaffer M, Fauriat C, Ringdén O, Remberger M, Hammarstedt C, Barrett AJ, Ljungman P, Ljunggren HG, Malmberg KJ. Björklund AT, et al. Blood. 2010 Apr 1;115(13):2686-94. doi: 10.1182/blood-2009-07-229740. Epub 2010 Jan 22. Blood. 2010. PMID: 20097883 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

854 results

Search Page